A phase 1, multicenter, open-label study of the safety of two dose levels of a human monoclonal antibody to human αv integrins, intetumumab, in combination with docetaxel and prednisone in patients with castrate-resistant metastatic prostate cancer

Franklin Chu, Joel Picus, Paula M. Fracasso, Robert Dreicer, Zhihui Lang, Brenda J. Foster

Investigational New Drugs · 2010 · 29 citations · 17 references

Concepts

References

17